<DOC>
	<DOCNO>NCT01789086</DOCNO>
	<brief_summary>This trial conduct Europe . The purpose trial ass safety , tolerability pharmacokinetics ( exposure trial drug body ) liraglutide obese adolescent subject age 12 17 year .</brief_summary>
	<brief_title>A Randomised , Double-blind , Placebo-controlled Trial Assess Safety , Tolerability Pharmacokinetics Liraglutide Obese Adolescent Subjects Aged 12 17 Years</brief_title>
	<detailed_description />
	<mesh_term>Nutrition Disorders</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Subjects Tanner stage 25 pubertal development time randomisation Body Mass Index ( BMI ) correspond 30 kg/m^2 adult international cutoff point 45 kg/m^2 equal 95th percentile age gender Fasting plasma glucose 7.0 mmol/L ( 126 mg/dL ) ( central laboratory analysis ) Subjects clinically diagnose secondary cause childhood obesity chromosomal abnormality ( e.g . Turner syndrome ) , syndromic obesity ( e.g . Prader Willi syndrome ) endocrinologic disorder ( e.g . Cushing Syndrome ) Subjects confirm diagnosis bulimia Subjects Tanner stage 1 development ( prepubertal ) Diagnosis type 1 type 2 diabetes mellitus judge investigator Previous treatment GLP1 ( glucagonlike peptide 1 ) receptor agonist ( e.g . exenatide liraglutide ) , DPP4 ( dipeptidyl peptidase4 ) inhibitor , orlistat weight lower medication , antipsychotic medication systemic corticosteroid within last 3 month Currently use use within 3 month screen trial : systemic treatment opinion investigator interfere PK ( pharmacokinetic ) , PD ( pharmacodynamic ) safety endpoint Surgical treatment obesity Past current chronic idiopathic pancreatitis , follow : amylase lipase 2 time UNR ( upper normal range ) , triglycerides 500 mg/dL , calcium UNR , history gallstone ( treated cholecystectomy ) Uncontrolled treat untreated hypertension 99th percentile age gender child History major depressive disorder history severe psychiatric disorder ( e.g . schizophrenia bipolar disorder ) could opinion investigator interfere trial compliance subject safety Subjects history suicide attempt history suicidal behaviour within past month entry trial</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>